A modified technique for insertion of intraperitoneal port for chemotherapy

Journal of Surgical Oncology

Volumn 90, Issue 4, 2005, Pages 247-248

  Liou, Wen Shiung ^a,b   Teng, Nelson N H ^a   Chan, John K ^a,c  

^a STANFORD CANCER INSTITUTE   (United States)

^b KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Intraperitoneal catheter; Modified technique

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CATHETER; FEMALE; GYNECOLOGIC CANCER; HUMAN; INCISION; INTRAPERITONEAL DRUG ADMINISTRATION; LAPAROSCOPY; OVARY CANCER; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

ANTINEOPLASTIC AGENTS; CATHETERS, INDWELLING; HUMANS; INFUSIONS, PARENTERAL; NEOPLASMS; RISK;

EID: 20044379574     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20255     Document Type: Article

References (7)

1. Alberts DS, Liu PY, Hannigan EV, et al.: Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996;335:1950-1955.
2. Armstrong DK, Bundy BN, Baergen R, et al.: Randomized phase III study of intravenous (IV) paclitaxel and cisplatin versus IV paclitaxel, intraperitoneal (IP) csiplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial (GOG172). Proc Am Soc Clin Oncol Abstr #803 2002.
3. Markman M, Bundy BN, Alberts DS, et al.: Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 2001;19:1001-1007.
4. Walker JL, Amstrong D, Bundy BN, et al.: 35th Annual Meeting of Society of Gynecologic. Oncologists abstract #20, 2004
5. Makhija S, Leitao M, Sabbatini P, et al.: Complications associated with intraperitoneal chemotherapy catheters. Gynecol Oncol 2001;81:77-81.
6. Sakuragi N, Nakajima A, Nomura E, et al.: Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma. Gynecol Oncol 2000;79:420-423.
7. Topuz E, Salihoglu Y, Aydiner A, et al.: Celsite port and catheter as an intraperitoneal access device in the treatment of ovarian cancer. J Surg Oncol 2000;74:223-226.